Susceptible gene single nucleotide polymorphism and hemorrhage risk in patients with brain arteriovenous malformation

被引:13
作者
Jiang, Nan [2 ]
Li, Xuesong [1 ]
Qi, Tiewei [2 ]
Guo, Shaolei [1 ]
Liang, Feng [1 ]
Huang, Zhengsong [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510080, Guangdong, Peoples R China
关键词
Brain arteriovenous malformation; Hemorrhage risk; Single nucleotide polymorphism; GROWTH-FACTOR-BETA; INTERLEUKIN-17; ACTIVATION; ISCHEMIA;
D O I
10.1016/j.jocn.2011.02.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The relationship between single nucleotide polymorphism (SNP) of interleukin-17 (IL-17A), transforming growth factor beta (TGF-beta), as well as its receptor (TGFR-beta 2) and susceptibility to intracerebral hemorrhage in patients with brain arteriovenous malformation (BAVM) was investigated in the present study. A total of 53 patients with BAVM and 120 healthy controls were recruited, all of whom were Han Chinese from South China. There were no statistically significant differences in the IL-17A-197 guanine/adenine (G/A) or TGF-beta 1-509 cytosine/thymine (C/T) genotypes or gene frequencies between BAVM patients and controls (p > 0.05), but the gene frequency of the TGER-beta 2-875 A/G genotype in patients with BAVM was significantly higher (p < 0.05). Furthermore, the frequencies of the G allele of IL-17A-197 G/A and TGFR-beta 2-875 A/G in BAVM patients with hemorrhage were higher than those without hemorrhage. TGFR-beta 2-875 G/G genotype is a risk factor for BAVM, and the IL-17A-197 G/A and TGFR-beta 2-875 A/G genotype is closely related to hemorrhage risk for patients with BAVM. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1279 / 1281
页数:3
相关论文
共 10 条
[1]   Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT):: Correlation of genotype with phenotype [J].
Bossler, Aaron D. ;
Richards, Jennifer ;
George, Cicily ;
Godmilow, Lynn ;
Ganguly, Arupa .
HUMAN MUTATION, 2006, 27 (07) :667-675
[2]   Transforming growth factor-β -: A neuroprotective factor in cerebral ischemia [J].
Dhandapani, KM ;
Brann, DW .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2003, 39 (01) :13-22
[3]  
Hashimoto T, 2005, NEUROSURGERY, V56, P1058
[4]   TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia - Dose-response relationship and potential neuroprotective mechanisms [J].
HenrichNoack, P ;
Prehn, JHM ;
Krieglstein, J .
STROKE, 1996, 27 (09) :1609-1614
[5]  
Huang SH, 2004, ALLERGY ASTHMA PROC, V25, P17
[6]   Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis [J].
Ishizu, T ;
Osoegawa, M ;
Mei, FJ ;
Kikuchi, H ;
Tanaka, M ;
Takakura, Y ;
Minohara, M ;
Murai, H ;
Mihara, F ;
Taniwaki, T ;
Kira, J .
BRAIN, 2005, 128 :988-1002
[7]  
Kim H, 2008, ACTA NEUROCHIR SUPPL, V105, P199
[8]   Transforming growth factor-β regulation of immune responses [J].
Li, Ming O. ;
Wan, Yisong Y. ;
Sanjabi, Shomyseh ;
Robertson, Anna-Karin L. ;
Flavell, Richard A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :99-146
[9]   Inducible nitric oxide synthase activation by interleukin-17 [J].
Miljkovic, D ;
Trajkovic, V .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (01) :21-32
[10]   Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3,-13 and aggrecanase-1 genes in articular chondrocytes [J].
Sylvester, J ;
Liacini, A ;
Li, WQ ;
Zafarullah, M .
CELLULAR SIGNALLING, 2004, 16 (04) :469-476